Chinese And Western Medicine Combined Treatment Of Kidney And Blood Stasis Type Of Benign Prostatic Hyperplasia Clinical Studies

Objectives:Through the LongBishu capsule and Doxazosin treats kidney deficiency and blood stasis type of benign prostatic hyperplasia in clinical research, Observes LongBishu capsule and Doxazosin to treat this disease the clinical effectiveness and safety.Methods:With the double-blind, randomized, controlled clinical research method, the selection of patients with BPH60cases, divided into two groups, indicating that the treatment group and control group, each group of30cases, the treatment group with LongBishu capsule and Doxazosin, the control group was close Doxazosin and LongBishu capsule placebo.2months for a period of treatment, observe a course of three. After three treatments (June) after treatment, which we assess the therapeutic effects by observing the improvements of the TCM Syndrome marks, the international prostate symptom score (I-PSS), voiding symptoms on quality of life (QOL), Prostate volume, residual urine volume, maximum uroflow rate changes of detection before and after the treatment.All results are statistically analyzed with SPSS17.0, and P≤0.05show there is a significant difference, having statistical sense.Results:In the treatment group, The cure rate was17.9%, the rate of the marked effective cases was46.4%, the rate of effective cases was32.1%. and the rate of inefficacy was3.6%, The rate of total effective was96.4%; compared to control groups (Display the cure rate was17.9%, the marked efficiency rate was29.7%, the effective rate was37.0%, the inefficacy rate was25.9%, The total effective rate was74.1%), the total significant difference has statistical sense (P<0.05), In the areas of the TCM Syndrome marks, the international prostate gland symptom grade (I-PSS), the urination symptom to quality of life influence (QOL), residual urine volume, maximum uroflow rate, both groups show significant improvements after the treatment (P<0.05). But in the prostate mass than two groups, the treatment group on narrowing prostate olume has certain effect (P<0.05), and the control group to prostate volume without change, the difference was not statistically significant (P>0.05).Conclusion:the LongBishu capsule and Doxazosin was effective in the treatment of benign prostatic hyperplasia and could enhance the efficacy of the cure rate and manifest improvement rate, reduce IPSS integral, improve the quality of life of urination symptoms affect, improve the quality of life of the patients, reduce symptom scores of traditional Chinese medicine, reduce prostate olume, especially for those people with obvious urinary symptoms.As a treatment for the disease can be a good choice.